350 related articles for article (PubMed ID: 35983756)
1. Proteasomal Degradation of TRAF2 Mediates Mitochondrial Dysfunction in Doxorubicin-Cardiomyopathy.
Dhingra R; Rabinovich-Nikitin I; Rothman S; Guberman M; Gang H; Margulets V; Jassal DS; Alagarsamy KN; Dhingra S; Valenzuela Ripoll C; Billia F; Diwan A; Javaheri A; Kirshenbaum LA
Circulation; 2022 Sep; 146(12):934-954. PubMed ID: 35983756
[TBL] [Abstract][Full Text] [Related]
2. Impaired NF-κB signalling underlies cyclophilin D-mediated mitochondrial permeability transition pore opening in doxorubicin cardiomyopathy.
Dhingra R; Guberman M; Rabinovich-Nikitin I; Gerstein J; Margulets V; Gang H; Madden N; Thliveris J; Kirshenbaum LA
Cardiovasc Res; 2020 May; 116(6):1161-1174. PubMed ID: 31566215
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2.
Alvarez SE; Harikumar KB; Hait NC; Allegood J; Strub GM; Kim EY; Maceyka M; Jiang H; Luo C; Kordula T; Milstien S; Spiegel S
Nature; 2010 Jun; 465(7301):1084-8. PubMed ID: 20577214
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor receptor-associated factor 2 mediates mitochondrial autophagy.
Yang KC; Ma X; Liu H; Murphy J; Barger PM; Mann DL; Diwan A
Circ Heart Fail; 2015 Jan; 8(1):175-87. PubMed ID: 25339503
[TBL] [Abstract][Full Text] [Related]
5. The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD.
Uematsu A; Kido K; Takahashi H; Takahashi C; Yanagihara Y; Saeki N; Yoshida S; Maekawa M; Honda M; Kai T; Shimizu K; Higashiyama S; Imai Y; Tokunaga F; Sawasaki T
J Biol Chem; 2019 Sep; 294(38):14135-14148. PubMed ID: 31366726
[TBL] [Abstract][Full Text] [Related]
6. Mitochonic acid 5 rescues cardiomyocytes from doxorubicin-induced toxicity via repressing the TNF-α/NF-κB/NLRP3-mediated pyroptosis.
Zha W; Zhao Q; Xiao Y; Gan Y; Wei J; Yu M; Xu Y; Xu Q; Wu S; Yu W
Int Immunopharmacol; 2023 Oct; 123():110736. PubMed ID: 37549513
[TBL] [Abstract][Full Text] [Related]
7. The deubiquitinating enzyme OTUD7b protects dendritic cells from TNF-induced apoptosis by stabilizing the E3 ligase TRAF2.
Harit K; Bhattacharjee R; Matuschewski K; Becker J; Kalinke U; Schlüter D; Nishanth G
Cell Death Dis; 2023 Jul; 14(7):480. PubMed ID: 37516734
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin-specific protease 4 (USP4) targets TRAF2 and TRAF6 for deubiquitination and inhibits TNFα-induced cancer cell migration.
Xiao N; Li H; Luo J; Wang R; Chen H; Chen J; Wang P
Biochem J; 2012 Feb; 441(3):979-86. PubMed ID: 22029577
[TBL] [Abstract][Full Text] [Related]
9. Deubiquitinase OTUB1 regulates doxorubicin-induced cardiotoxicity via deubiquitinating c-MYC.
Xu F; Zang T; Chen H; Zhou C; Wang R; Yu Y; Shen L; Qian J; Ge J
Cell Signal; 2024 Jan; 113():110937. PubMed ID: 37871668
[TBL] [Abstract][Full Text] [Related]
10. TRAF2 suppresses basal IKK activity in resting cells and TNFalpha can activate IKK in TRAF2 and TRAF5 double knockout cells.
Zhang L; Blackwell K; Thomas GS; Sun S; Yeh WC; Habelhah H
J Mol Biol; 2009 Jun; 389(3):495-510. PubMed ID: 19409903
[TBL] [Abstract][Full Text] [Related]
11. Curcumin Ameliorates Doxorubicin-Induced Cardiotoxicity and Hepatotoxicity Via Suppressing Oxidative Stress and Modulating iNOS, NF-κB, and TNF-α in Rats.
Ibrahim Fouad G; Ahmed KA
Cardiovasc Toxicol; 2022 Feb; 22(2):152-166. PubMed ID: 34837640
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitin ligase CHIP induces TRAF2 proteasomal degradation and NF-κB inactivation to regulate breast cancer cell invasion.
Jang KW; Lee KH; Kim SH; Jin T; Choi EY; Jeon HJ; Kim E; Han YS; Chung JH
J Cell Biochem; 2011 Dec; 112(12):3612-20. PubMed ID: 21793045
[TBL] [Abstract][Full Text] [Related]
13. Blockade of L-type Ca
Ikeda S; Matsushima S; Okabe K; Ikeda M; Ishikita A; Tadokoro T; Enzan N; Yamamoto T; Sada M; Deguchi H; Morimoto S; Ide T; Tsutsui H
Sci Rep; 2019 Jul; 9(1):9850. PubMed ID: 31285514
[TBL] [Abstract][Full Text] [Related]
14. Cardamonin protects against doxorubicin-induced cardiotoxicity in mice by restraining oxidative stress and inflammation associated with Nrf2 signaling.
Qi W; Boliang W; Xiaoxi T; Guoqiang F; Jianbo X; Gang W
Biomed Pharmacother; 2020 Feb; 122():109547. PubMed ID: 31918264
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor (TNF) receptor-associated factor (TRAF)-interacting protein (TRIP) negatively regulates the TRAF2 ubiquitin-dependent pathway by suppressing the TRAF2-sphingosine 1-phosphate (S1P) interaction.
Park ES; Choi S; Shin B; Yu J; Yu J; Hwang JM; Yun H; Chung YH; Choi JS; Choi Y; Rho J
J Biol Chem; 2015 Apr; 290(15):9660-73. PubMed ID: 25716317
[TBL] [Abstract][Full Text] [Related]
16. COX5A Alleviates Doxorubicin-Induced Cardiotoxicity by Suppressing Oxidative Stress, Mitochondrial Dysfunction and Cardiomyocyte Apoptosis.
Zhang P; Lu H; Wu Y; Lu D; Li C; Yang X; Chen Z; Qian J; Ge J
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373547
[TBL] [Abstract][Full Text] [Related]
17. TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2.
Li X; Yang Y; Ashwell JD
Nature; 2002 Mar; 416(6878):345-7. PubMed ID: 11907583
[TBL] [Abstract][Full Text] [Related]
18. TRAF2 exerts opposing effects on basal and TNFα-induced activation of the classic IKK complex in hematopoietic cells in mice.
Zhang L; Blackwell K; Workman LM; Gibson-Corley KN; Olivier AK; Bishop GA; Habelhah H
J Cell Sci; 2016 Apr; 129(7):1455-67. PubMed ID: 26872784
[TBL] [Abstract][Full Text] [Related]
19. MD-1 Deficiency Accelerates Myocardial Inflammation and Apoptosis in Doxorubicin-Induced Cardiotoxicity by Activating the TLR4/MAPKs/Nuclear Factor kappa B (NF-κB) Signaling Pathway.
Zhang YJ; Huang H; Liu Y; Kong B; Wang G
Med Sci Monit; 2019 Oct; 25():7898-7907. PubMed ID: 31636246
[TBL] [Abstract][Full Text] [Related]
20. AIMP2 promotes TNFalpha-dependent apoptosis via ubiquitin-mediated degradation of TRAF2.
Choi JW; Kim DG; Park MC; Um JY; Han JM; Park SG; Choi EC; Kim S
J Cell Sci; 2009 Aug; 122(Pt 15):2710-5. PubMed ID: 19584093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]